Literature DB >> 32015038

Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.

Gabrielle Richard1,2, C Roger MacKenzie1,2, Kevin A Henry2,3, Evgeny Vinogradov2, J Christopher Hall1, Greg Hussack4.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that is inherently resistant to many antibiotics and represents an increasing threat due to the emergence of drug-resistant strains. There is a pressing need to develop innovative antimicrobials against this pathogen. In this study, we identified the O-specific antigen (OSA) of P. aeruginosa serotype O6 as a novel target for therapeutic intervention. Binding of monoclonal antibodies and antigen-binding fragments therefrom to O6 OSA leads to rapid outer membrane destabilization and inhibition of cell growth. The antimicrobial effect correlated directly with antibody affinity. Antibody binding to the O antigen of a second lipopolysaccharide (LPS) type present in P. aeruginosa or to the LPS core did not affect cell viability. Atomic force microscopy showed that antibody binding to OSA resulted in early flagellum loss, formation of membrane blebs, and eventually complete outer membrane loss. We hypothesize that antibody binding to OSA disrupts a key interaction in the P. aeruginosa outer membrane. © Crown copyright 2020.

Entities:  

Keywords:  AFM; LPS; O-specific antigen; antibacterial antibodies; atomic force microscopy; lipopolysaccharide; outer membrane disruption

Year:  2020        PMID: 32015038      PMCID: PMC7179301          DOI: 10.1128/AAC.02168-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  49 in total

1.  Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.

Authors:  J L Coleman; R C Rogers; J L Benach
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Modeling and docking of antibody structures with Rosetta.

Authors:  Brian D Weitzner; Jeliazko R Jeliazkov; Sergey Lyskov; Nicholas Marze; Daisuke Kuroda; Rahel Frick; Jared Adolf-Bryfogle; Naireeta Biswas; Roland L Dunbrack; Jeffrey J Gray
Journal:  Nat Protoc       Date:  2017-01-26       Impact factor: 13.491

3.  Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.

Authors:  Assaf Raz; Anna Serrano; Anaise Hernandez; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

4.  Cholesterol lipids of Borrelia burgdorferi form lipid rafts and are required for the bactericidal activity of a complement-independent antibody.

Authors:  Timothy J LaRocca; Jameson T Crowley; Brian J Cusack; Priyadarshini Pathak; Jordi Benach; Erwin London; Juan C Garcia-Monco; Jorge L Benach
Journal:  Cell Host Microbe       Date:  2010-10-21       Impact factor: 21.023

5.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units.

Authors:  Despoina Koulenti; Thiago Lisboa; Christian Brun-Buisson; Wolfgang Krueger; Antonio Macor; Jordi Sole-Violan; Emili Diaz; Arzu Topeli; Jan DeWaele; Antonio Carneiro; Ignacio Martin-Loeches; Apostolos Armaganidis; Jordi Rello
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

Review 7.  Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa.

Authors:  S G Wilkinson
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

8.  In vitro inhibition of Borrelia burgdorferi growth by antibodies.

Authors:  A Sadziene; P A Thompson; A G Barbour
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

9.  Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections.

Authors:  Stefanie Wagner; Roman Sommer; Stefan Hinsberger; Cenbin Lu; Rolf W Hartmann; Martin Empting; Alexander Titz
Journal:  J Med Chem       Date:  2016-02-18       Impact factor: 7.446

10.  Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models.

Authors:  Hoan N Le; Vuvi G Tran; Trang T T Vu; Emmanuelle Gras; Vien T M Le; Marcos Gabriel Pinheiro; Fábio Aguiar-Alves; Erika Schneider-Smith; Henry Clay Carter; Bret R Sellman; C Kendall Stover; Antonio DiGiandomenico; Binh An Diep
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

View more
  4 in total

1.  Detection of Pseudomonas aeruginosa Serogroup G Using Real-Time PCR for Novel Target Genes Identified Through Comparative Genomics.

Authors:  Chufang Wang; Qinghua Ye; Yu Ding; Jumei Zhang; Qihui Gu; Rui Pang; Hui Zhao; Juan Wang; Qingping Wu
Journal:  Front Microbiol       Date:  2022-06-24       Impact factor: 6.064

2.  Anti-Acinetobacter baumannii single-chain variable fragments show direct bactericidal activity.

Authors:  Eilnaz Basardeh; Somayeh Piri-Gavgani; Behnoush Soltanmohammadi; Mostafa Ghanei; Mir Davood Omrani; Mahdieh Soezi; Mohammad Ali Shokrgozar; Masoumeh Azizi; Abolfazl Fateh; Farzam Vaziri; Seyed Davar Siadat; Zahra Sharifzadeh; Fatemeh Rahimi-Jamnani
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532

3.  Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC1.

Authors:  Jirakrit Saetang; Surasak Sangkhathat; Nawaphat Jangphattananont; Wannakorn Khopanlert; Jakrawadee Julamanee; Varomyalin Tipmanee
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

4.  Bactericidal fully human single-chain fragment variable antibodies protect mice against methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Behnoush Soltanmohammadi; Somayeh Piri-Gavgani; Eilnaz Basardeh; Mostafa Ghanei; Masoumeh Azizi; Zabihollah Khaksar; Zahra Sharifzadeh; Farzad Badmasti; Mahdieh Soezi; Abolfazl Fateh; Parisa Azimi; Seyed Davar Siadat; Fahimeh Shooraj; Saeid Bouzari; Mir Davood Omrani; Fatemeh Rahimi-Jamnani
Journal:  Clin Transl Immunology       Date:  2021-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.